Delivery Order SPE2DB22D1017-SPE2DB25FF0DD

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $5,964.35. The contract is a firm fixed-price, non-set-aside delivery order with a completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract provides for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $14,287.26 and a performance period through April 11, 2024. The contract is a firm fixed price delivery order, with no set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,525.94, is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through November 26, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $56,453.62 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $12,019.76 and a period of performance through February 14, 2025. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $4,506.60 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,197.67, is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a prescription medication, with a ceiling value of $11,050.72 and a performance period through June 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $31,628.35 and an ultimate completion date of January 2, 2024. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product. The contract is a firm fixed-price delivery order, with no set-aside designation, awarded under an existing Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has a ceiling value of $27,247.38 and a period of performance ending on June 25, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0DD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $18,793.08 and a period of performance ending on November 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:10 PM